Save the date
5 march 2024
Brussels & online
Save the date
ESWI Respiratory Virus Summit 2024
Save the date: Tuesday 5 March 2024
RSV: Disease Impact and Innovation Strategies
ESWI Respiratory Virus Summit 2024 will take place in Brussels and online on Tuesday 5 March 2024.
Building on the 2023 session held at the ESWI conference in Valencia, ESWI is set to host this one-day hybrid summit that concentrates on the healthcare and economic impact of RSV disease, along with the potential solutions expected in the near future.
The inspiration for this event remains pertinent, as we continue to witness an increase in RSV infections and remarkable progress in technology and vaccine development. As a result, ESWI firmly believes that maintaining a keen focus on RSV is of utmost importance and in particular on the Science-and-Policy Interface of RSV.
Respiratory Syncytial Virus (RSV) is a common virus that affects all age groups with varying clinical effects. The virus is transmitted easily through coughing and sneezing with droplets containing the virus. RSV disease is a major burden in young children and older adults, causing hospitalisation and in acute cases, death. Prevention and treatment strategies could be available soon as multiple clinical trials are being held and are showing a high efficacy.
Call for Applications for ECaS Community is now closed
Thank you very much for your application. All applicants will be contacted when the review process is complete.
ESWI symposium 2023
ESWI symposium "RSV looking towards the future" at the Ninth ESWI Influenza Conference:
ESWI Webinar 2021
ESWI webinar "RSV Disease in a COVID-19 era"